PortfoliosLab logoPortfoliosLab logo
AYTU vs. SIDU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AYTU vs. SIDU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aytu BioPharma, Inc. (AYTU) and Sidus Space, Inc. (SIDU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AYTU achieves a -13.46% return, which is significantly lower than SIDU's -1.27% return.


AYTU

1D
-2.60%
1M
2.74%
YTD
-13.46%
6M
-15.09%
1Y
12.50%
3Y*
10.45%
5Y*
-54.31%
10Y*

SIDU

1D
-4.02%
1M
-39.45%
YTD
-1.27%
6M
35.37%
1Y
108.05%
3Y*
-46.72%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

AYTU vs. SIDU - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AYTU
Aytu BioPharma, Inc.
-13.46%52.94%-40.14%-24.87%-86.00%-19.64%
SIDU
Sidus Space, Inc.
-1.27%-35.92%-44.38%-91.92%-89.64%-61.04%

Correlation

The correlation between AYTU and SIDU is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Dec 14, 2021

0.15

The correlation between AYTU and SIDU shifts across timeframes, from 0.14 (3 years) to 0.28 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AYTU:

$23.65M

SIDU:

$76.72M

EPS

AYTU:

-$2.91

SIDU:

-$1.30

PS Ratio

AYTU:

0.47

SIDU:

39.53

PB Ratio

AYTU:

0.67

SIDU:

1.52

Total Revenue (TTM)

AYTU:

$56.60M

SIDU:

$1.78M

Gross Profit (TTM)

AYTU:

$36.14M

SIDU:

-$5.69M

EBITDA (TTM)

AYTU:

-$27.34M

SIDU:

-$28.01M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AYTU vs. SIDU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AYTU
AYTU Risk / Return Rank: 5050
Overall Rank
AYTU Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4848
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4848
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5151
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5252
Martin Ratio Rank

SIDU
SIDU Risk / Return Rank: 7272
Overall Rank
SIDU Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
SIDU Sortino Ratio Rank: 8282
Sortino Ratio Rank
SIDU Omega Ratio Rank: 7979
Omega Ratio Rank
SIDU Calmar Ratio Rank: 7171
Calmar Ratio Rank
SIDU Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AYTU vs. SIDU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Sidus Space, Inc. (SIDU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AYTUSIDUDifference
Sharpe ratioReturn per unit of total volatility

-0.33

Sortino ratioReturn per unit of downside risk

-1.68

Omega ratioGain probability vs. loss probability

1.09

1.29

-0.20

Calmar ratioReturn relative to maximum drawdown

0.35

1.57

-1.22

Martin ratioReturn relative to average drawdown

0.81

2.55

-1.75

AYTU vs. SIDU - Sharpe Ratio Comparison

The current AYTU Sharpe Ratio is 0.23, which is lower than the SIDU Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of AYTU and SIDU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AYTU vs. SIDU - Drawdown Comparison

The maximum AYTU drawdown since its inception was -100.00%, roughly equal to the maximum SIDU drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for AYTU and SIDU.


Loading charts...

Drawdown Indicators


AYTUSIDUDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-99.98%

-0.02%

Max Drawdown (1Y)

Largest decline over 1 year

-35.47%

-69.05%

+33.58%

Max Drawdown (3Y)

Largest decline over 3 years

-70.24%

-96.91%

+26.67%

Max Drawdown (5Y)

Largest decline over 5 years

-99.09%

Current Drawdown

Current decline from peak

-100.00%

-99.89%

-0.11%

Average Drawdown

Average peak-to-trough decline

-95.27%

-96.26%

+0.99%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.55%

42.47%

-26.92%

Volatility

AYTU vs. SIDU - Volatility Comparison

The current volatility for Aytu BioPharma, Inc. (AYTU) is 16.13%, while Sidus Space, Inc. (SIDU) has a volatility of 49.37%. This indicates that AYTU experiences smaller price fluctuations and is considered to be less risky than SIDU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AYTUSIDUDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.13%

49.37%

-33.24%

Volatility (6M)

Calculated over the trailing 6-month period

34.71%

150.77%

-116.06%

Volatility (1Y)

Calculated over the trailing 1-year period

55.79%

194.71%

-138.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.38%

230.12%

-144.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

187.85%

230.12%

-42.27%

Dividends

AYTU vs. SIDU - Dividend Comparison

Neither AYTU nor SIDU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

AYTU vs. SIDU - Financials Comparison

This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Sidus Space, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M20222023202420252026
12.41M
-1.02M
(AYTU) Total Revenue
(SIDU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


AYTU and SIDU have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SIDU has higher volatility (49.37%) compared to AYTU (16.13%). In terms of maximum drawdown, AYTU dropped -100.00% vs SIDU's -99.98%.

SIDU currently has the higher Sharpe Ratio (0.56 vs 0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AYTU and SIDU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer